TY - JOUR
T1 - Incidence, prevalence, and clearance of type-specific human papillomavirus infections
T2 - The Young Women's Health Study
AU - Giuliano, Anna R.
AU - Harris, Robin
AU - Sedjo, Rebecca L.
AU - Baldwin, Susie
AU - Roe, Denise
AU - Papenfuss, Mary R.
AU - Abrahamsen, Martha
AU - Inserra, Paula
AU - Olvera, Sandra
AU - Hatch, Kenneth
N1 - Funding Information:
Financial support: Arizona Disease Research Commission (grant 9710); National Cancer Institute (grant KO7-CA60885).
PY - 2002/8/15
Y1 - 2002/8/15
N2 - The natural history of type-specific human papillomavirus (HPV) infections was examined in a cohort of 331 Women aged 18-35 years who self-referred for routine gynecological care. Participants underwent a gynecological examination at baseline and at ∼4 and ∼10 months after baseline. Cervical samples were collected for HPV testing and genotyping at each visit, as was information on reproductive, sexual, and medical histories. The rate of new HPV infections was 2.9% per month; the highest rates were observed for HPV types 16, 39, 84, and 51. Among women who tested negative for HPV at baseline, the cumulative probability of acquiring an oncogenic HPV strain during a 12-month follow-up period was 0.32, compared with 0.18 for nononcogenic strains. Women who had had ≥ 1 new male sex partner in the recent past were significantly more likely to acquire a new HPV infection (relative hazard, 2.39; 95% confidence interval, 1.20-4.76). The median time to clearance of infection was significantly longer for oncogenic strains (9.8 months) than for nononcogenic strains (4.3 months).
AB - The natural history of type-specific human papillomavirus (HPV) infections was examined in a cohort of 331 Women aged 18-35 years who self-referred for routine gynecological care. Participants underwent a gynecological examination at baseline and at ∼4 and ∼10 months after baseline. Cervical samples were collected for HPV testing and genotyping at each visit, as was information on reproductive, sexual, and medical histories. The rate of new HPV infections was 2.9% per month; the highest rates were observed for HPV types 16, 39, 84, and 51. Among women who tested negative for HPV at baseline, the cumulative probability of acquiring an oncogenic HPV strain during a 12-month follow-up period was 0.32, compared with 0.18 for nononcogenic strains. Women who had had ≥ 1 new male sex partner in the recent past were significantly more likely to acquire a new HPV infection (relative hazard, 2.39; 95% confidence interval, 1.20-4.76). The median time to clearance of infection was significantly longer for oncogenic strains (9.8 months) than for nononcogenic strains (4.3 months).
UR - http://www.scopus.com/inward/record.url?scp=0037103398&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0037103398&partnerID=8YFLogxK
U2 - 10.1086/341782
DO - 10.1086/341782
M3 - Article
C2 - 12195372
AN - SCOPUS:0037103398
SN - 0022-1899
VL - 186
SP - 462
EP - 469
JO - Journal of Infectious Diseases
JF - Journal of Infectious Diseases
IS - 4
ER -